Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Interferon-β-1a

Exacerbation of systemic lupus erythematosus: case report

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Anbarasan D, Kister I, Herbert J.Worsening of lupus symptoms after IFN-b1a injections in a patient with MS and systemic lupus erythematosis. World Congress on Treatment and Research in Multiple Sclerosis: abstr. P77, 17 Sep 2008. Available from: URL: http://www.msmontreal.org - USA

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Interferon-β-1a. React. Wkly. 1222, 21 (2008). https://doi.org/10.2165/00128415-200812220-00062

    Download citation

    Keywords

    • Public Health
    • Multiple Sclerosis
    • Systemic Lupus Erythematosus
    • Antibody Titer
    • Abate